These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36222599)

  • 1. Polysubstance use profiles among US adults using Kratom (Mitragyna speciosa): A latent class analysis using The National Survey on Drug Use and Health (NSDUH).
    Falise AM; Hoeflich CC; Nutley SK; Lopez-Quintero C; Striley CW
    Am J Addict; 2023 Jan; 32(1):76-80. PubMed ID: 36222599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Prescribed Buprenorphine Use Mediates the Relationship between Heroin Use and Kratom Use among a Sample of Polysubstance Users.
    Smith KE; Bunting AM; Walker R; Hall MT; Grundmann O; Castillo O
    J Psychoactive Drugs; 2019; 51(4):311-322. PubMed ID: 30961450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kratom Use Among U.S. Adolescents: Analyses of the 2019 National Survey on Drug Use and Health.
    Sharma V; Cottler LB; Bares CB; Lopez-Quintero C
    J Adolesc Health; 2022 Apr; 70(4):677-681. PubMed ID: 34836801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study.
    Schimmel J; Amioka E; Rockhill K; Haynes CM; Black JC; Dart RC; Iwanicki JL
    Addiction; 2021 Jan; 116(1):176-181. PubMed ID: 32285981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and characteristics of self-reported kratom use in a representative US general population sample.
    Covvey JR; Vogel SM; Peckham AM; Evoy KE
    J Addict Dis; 2020; 38(4):506-513. PubMed ID: 32657217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Kratom (Mitragyna speciosa Korth.) Among People Who Co-use Heroin and Methamphetamine in Malaysia.
    Singh D; Narayanan S; Vicknasingam B; Prozialeck WC; Smith KE; Corazza O; Henningfield JE; Grundmann O
    J Addict Med; 2022 Mar-Apr 01; 16(2):223-228. PubMed ID: 34001777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users.
    Singh D; Müller CP; Vicknasingam BK
    Drug Alcohol Depend; 2014 Jun; 139():132-7. PubMed ID: 24698080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the self-reported motivations of kratom (
    Grundmann O; Veltri CA; Morcos D; Knightes D; Smith KE; Singh D; Corazza O; Cinosi E; Martinotti G; Walsh Z; Swogger MT
    Am J Drug Alcohol Abuse; 2022 Jul; 48(4):433-444. PubMed ID: 35389321
    [No Abstract]   [Full Text] [Related]  

  • 9. Examining the heterogeneity of polysubstance use patterns in young adulthood by age and college attendance.
    Stevens AK; Gunn RL; Sokolovsky AW; Colby SM; Jackson KM
    Exp Clin Psychopharmacol; 2022 Oct; 30(5):701-713. PubMed ID: 33970653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of polysubstance use among adults in Malaysia-A latent class analysis.
    Rodzlan Hasani WS; Robert Lourdes TG; Ganapathy SS; Ab Majid NL; Abd Hamid HA; Mohd Yusoff MF
    PLoS One; 2023; 18(1):e0264593. PubMed ID: 36649298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kratom use as more than a "self-treatment".
    Smith KE; Dunn KE; Rogers JM; Grundmann O; McCurdy CR; Garcia-Romeu A; Schriefer D; Swogger MT; Epstein DH
    Am J Drug Alcohol Abuse; 2022 Nov; 48(6):684-694. PubMed ID: 35767669
    [No Abstract]   [Full Text] [Related]  

  • 12. The association between E-cigarette use and Kratom use among US adults.
    Lee J; Terashima JP; Parker MA
    Prev Med; 2022 Nov; 164():107295. PubMed ID: 36208816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National polydrug use patterns among people who misuse prescription opioids and people who use heroin. Results from the National Household Survey on Drug Use and Health.
    Bobashev GV; Warren LK
    Drug Alcohol Depend; 2022 Sep; 238():109553. PubMed ID: 35905594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of Lifetime Nonmedical Opioid, Methamphetamine, and Kratom Use within a Nationally Representative US Sample.
    Smith KE; Rogers JM; Strickland JC
    J Psychoactive Drugs; 2022; 54(5):429-439. PubMed ID: 34842079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kratom use and mental health: A systematic review.
    Swogger MT; Walsh Z
    Drug Alcohol Depend; 2018 Feb; 183():134-140. PubMed ID: 29248691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program.
    Smith KE; Lawson T
    Drug Alcohol Depend; 2017 Nov; 180():340-348. PubMed ID: 28950240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kratom use categories and their associations with co-occurring substance use and mental health disorder symptoms during the COVID-19 pandemic.
    Adzrago D; Obekpa EO; Suragh TA; John ER; Yeh PG; Gallardo KR; Wilkerson JM
    Drug Alcohol Depend; 2022 Oct; 239():109605. PubMed ID: 36027671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Benzodiazepines among Kratom (
    Singh D; Narayanan S; Grundmann O; Boyer EW; Vicknasingam B
    J Psychoactive Drugs; 2020; 52(1):86-92. PubMed ID: 31218929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Health Impact of Long-Term Kratom (
    Saingam D; Singh D; Geater AF; Assanangkornchai S; Jitpiboon W; Latkin C
    Subst Use Misuse; 2023; 58(10):1212-1225. PubMed ID: 37270449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-Report Data on Regular Consumption of Illicit Drugs and HIV Risk Behaviors after Kratom (
    Saref A; Suraya S; Singh D; Grundmann O; Narayanan S; Swogger MT; Prozialeck WC; Boyer E; Balasingam V
    J Psychoactive Drugs; 2020; 52(2):138-144. PubMed ID: 31682782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.